Biotech Business
Biotech Hub Announces New Tenant
Published in Cancer Weekly, May 29th, 2007
"We're very happy to have Angiogen as a tenant at the NC Research Campus," said Higgs. "We continue to reach out and find success with exciting companies like Angiogen in the medical devices, diagnostics, health and wellness and agri-bio tech fields."
Angiogen's mission is to develop novel oncology therapies, which will benefit those suffering from cancer. The company is preparing for a Phase I trial with its lead anti-angiogenesis drug, the Angiostatic Cocktail. Prior results in a short Phase I trial and in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-05-29)
More Articles from Cancer Weekly
- Cancer Gene Therapy
Medical Research Scientists Make Ethical Value Judgments in Research - Cancer Gene Therapy
Researchers Find a Peptide That Encourages HIV Infection - Cancer Gene Therapy
Researchers Use "Virtual Iraq" Simulation to Study Post-Traumatic Stress Disorder - Astrocytoma
Clinical Results on Phase IIb-study with AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion - Bird Flu
Carrington Reports First Quarter 2007 Results - Bird Flu
FDA Approves Phase I Clinical Trial Using Ichor's TriGrid System and DNA Vaccine for Melanoma Developed at Sloan-Kettering - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
